Global Mezlocillin Sodium Injection Market Research Report 2025

Publication ID:

PB505257770

Publication Date:

May 30, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Mezlocillin Sodium Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mezlocillin sodium injection is used for respiratory system, urinary system, digestive system, gynecology and reproductive organs and other infections caused by sensitive strains of Gram-negative bacilli such as Escherichia coli, Enterobacter, and Proteus, such as sepsis, suppuration, etc. Meningitis, peritonitis, osteomyelitis, skin and soft tissue infections, and eye, ear, nose, and throat infections.
North American market for Mezlocillin Sodium Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mezlocillin Sodium Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mezlocillin Sodium Injection include Biosynth, INOPHA GmbH, North China Pharmaceutical, Hailing Pharm, Hainan General Sanyang Pharmaceutical, Sichuan Pharmaceutical, Jiangsu Weiqida Pharmaceutical, Shanghai Shyndec Pharmaceutical, Shandong Lukang Pharmaceutical, Hainan Meihao Xilin Biopharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mezlocillin Sodium Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mezlocillin Sodium Injection.
The Mezlocillin Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mezlocillin Sodium Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mezlocillin Sodium Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Biosynth
INOPHA GmbH
North China Pharmaceutical
Hailing Pharm
Hainan General Sanyang Pharmaceutical
Sichuan Pharmaceutical
Jiangsu Weiqida Pharmaceutical
Shanghai Shyndec Pharmaceutical
Shandong Lukang Pharmaceutical
Hainan Meihao Xilin Biopharmaceutical
Shanxi C&Y Pharmaceutical Group
REYOUNG
Suzhou Erye Pharmaceutical
Segment by Type
Less Than 1g
1g-3g
More Than 3g
Segment by Application
For Human
For Veterinary
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mezlocillin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mezlocillin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Mezlocillin Sodium Injection Market Overview
1.1 Product Definition
1.2 Mezlocillin Sodium Injection by Type
1.2.1 Global Mezlocillin Sodium Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Less Than 1g
1.2.3 1g-3g
1.2.4 More Than 3g
1.3 Mezlocillin Sodium Injection by Application
1.3.1 Global Mezlocillin Sodium Injection Market Value by Application (2024 VS 2031)
1.3.2 For Human
1.3.3 For Veterinary
1.4 Global Mezlocillin Sodium Injection Market Size Estimates and Forecasts
1.4.1 Global Mezlocillin Sodium Injection Revenue 2020-2031
1.4.2 Global Mezlocillin Sodium Injection Sales 2020-2031
1.4.3 Global Mezlocillin Sodium Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mezlocillin Sodium Injection Market Competition by Manufacturers
2.1 Global Mezlocillin Sodium Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mezlocillin Sodium Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mezlocillin Sodium Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mezlocillin Sodium Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mezlocillin Sodium Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mezlocillin Sodium Injection, Product Type & Application
2.7 Global Key Manufacturers of Mezlocillin Sodium Injection, Date of Enter into This Industry
2.8 Global Mezlocillin Sodium Injection Market Competitive Situation and Trends
2.8.1 Global Mezlocillin Sodium Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mezlocillin Sodium Injection Players Market Share by Revenue
2.8.3 Global Mezlocillin Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mezlocillin Sodium Injection Market Scenario by Region
3.1 Global Mezlocillin Sodium Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mezlocillin Sodium Injection Sales by Region: 2020-2031
3.2.1 Global Mezlocillin Sodium Injection Sales by Region: 2020-2025
3.2.2 Global Mezlocillin Sodium Injection Sales by Region: 2026-2031
3.3 Global Mezlocillin Sodium Injection Revenue by Region: 2020-2031
3.3.1 Global Mezlocillin Sodium Injection Revenue by Region: 2020-2025
3.3.2 Global Mezlocillin Sodium Injection Revenue by Region: 2026-2031
3.4 North America Mezlocillin Sodium Injection Market Facts & Figures by Country
3.4.1 North America Mezlocillin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mezlocillin Sodium Injection Sales by Country (2020-2031)
3.4.3 North America Mezlocillin Sodium Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mezlocillin Sodium Injection Market Facts & Figures by Country
3.5.1 Europe Mezlocillin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mezlocillin Sodium Injection Sales by Country (2020-2031)
3.5.3 Europe Mezlocillin Sodium Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mezlocillin Sodium Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Mezlocillin Sodium Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mezlocillin Sodium Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Mezlocillin Sodium Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mezlocillin Sodium Injection Market Facts & Figures by Country
3.7.1 Latin America Mezlocillin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mezlocillin Sodium Injection Sales by Country (2020-2031)
3.7.3 Latin America Mezlocillin Sodium Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mezlocillin Sodium Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Mezlocillin Sodium Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mezlocillin Sodium Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mezlocillin Sodium Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mezlocillin Sodium Injection Sales by Type (2020-2031)
4.1.1 Global Mezlocillin Sodium Injection Sales by Type (2020-2025)
4.1.2 Global Mezlocillin Sodium Injection Sales by Type (2026-2031)
4.1.3 Global Mezlocillin Sodium Injection Sales Market Share by Type (2020-2031)
4.2 Global Mezlocillin Sodium Injection Revenue by Type (2020-2031)
4.2.1 Global Mezlocillin Sodium Injection Revenue by Type (2020-2025)
4.2.2 Global Mezlocillin Sodium Injection Revenue by Type (2026-2031)
4.2.3 Global Mezlocillin Sodium Injection Revenue Market Share by Type (2020-2031)
4.3 Global Mezlocillin Sodium Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mezlocillin Sodium Injection Sales by Application (2020-2031)
5.1.1 Global Mezlocillin Sodium Injection Sales by Application (2020-2025)
5.1.2 Global Mezlocillin Sodium Injection Sales by Application (2026-2031)
5.1.3 Global Mezlocillin Sodium Injection Sales Market Share by Application (2020-2031)
5.2 Global Mezlocillin Sodium Injection Revenue by Application (2020-2031)
5.2.1 Global Mezlocillin Sodium Injection Revenue by Application (2020-2025)
5.2.2 Global Mezlocillin Sodium Injection Revenue by Application (2026-2031)
5.2.3 Global Mezlocillin Sodium Injection Revenue Market Share by Application (2020-2031)
5.3 Global Mezlocillin Sodium Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biosynth
6.1.1 Biosynth Company Information
6.1.2 Biosynth Description and Business Overview
6.1.3 Biosynth Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biosynth Mezlocillin Sodium Injection Product Portfolio
6.1.5 Biosynth Recent Developments/Updates
6.2 INOPHA GmbH
6.2.1 INOPHA GmbH Company Information
6.2.2 INOPHA GmbH Description and Business Overview
6.2.3 INOPHA GmbH Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 INOPHA GmbH Mezlocillin Sodium Injection Product Portfolio
6.2.5 INOPHA GmbH Recent Developments/Updates
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Company Information
6.3.2 North China Pharmaceutical Description and Business Overview
6.3.3 North China Pharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 North China Pharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments/Updates
6.4 Hailing Pharm
6.4.1 Hailing Pharm Company Information
6.4.2 Hailing Pharm Description and Business Overview
6.4.3 Hailing Pharm Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Hailing Pharm Mezlocillin Sodium Injection Product Portfolio
6.4.5 Hailing Pharm Recent Developments/Updates
6.5 Hainan General Sanyang Pharmaceutical
6.5.1 Hainan General Sanyang Pharmaceutical Company Information
6.5.2 Hainan General Sanyang Pharmaceutical Description and Business Overview
6.5.3 Hainan General Sanyang Pharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hainan General Sanyang Pharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.5.5 Hainan General Sanyang Pharmaceutical Recent Developments/Updates
6.6 Sichuan Pharmaceutical
6.6.1 Sichuan Pharmaceutical Company Information
6.6.2 Sichuan Pharmaceutical Description and Business Overview
6.6.3 Sichuan Pharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sichuan Pharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.6.5 Sichuan Pharmaceutical Recent Developments/Updates
6.7 Jiangsu Weiqida Pharmaceutical
6.7.1 Jiangsu Weiqida Pharmaceutical Company Information
6.7.2 Jiangsu Weiqida Pharmaceutical Description and Business Overview
6.7.3 Jiangsu Weiqida Pharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Weiqida Pharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.7.5 Jiangsu Weiqida Pharmaceutical Recent Developments/Updates
6.8 Shanghai Shyndec Pharmaceutical
6.8.1 Shanghai Shyndec Pharmaceutical Company Information
6.8.2 Shanghai Shyndec Pharmaceutical Description and Business Overview
6.8.3 Shanghai Shyndec Pharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai Shyndec Pharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.8.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
6.9 Shandong Lukang Pharmaceutical
6.9.1 Shandong Lukang Pharmaceutical Company Information
6.9.2 Shandong Lukang Pharmaceutical Description and Business Overview
6.9.3 Shandong Lukang Pharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shandong Lukang Pharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.9.5 Shandong Lukang Pharmaceutical Recent Developments/Updates
6.10 Hainan Meihao Xilin Biopharmaceutical
6.10.1 Hainan Meihao Xilin Biopharmaceutical Company Information
6.10.2 Hainan Meihao Xilin Biopharmaceutical Description and Business Overview
6.10.3 Hainan Meihao Xilin Biopharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hainan Meihao Xilin Biopharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.10.5 Hainan Meihao Xilin Biopharmaceutical Recent Developments/Updates
6.11 Shanxi C&Y Pharmaceutical Group
6.11.1 Shanxi C&Y Pharmaceutical Group Company Information
6.11.2 Shanxi C&Y Pharmaceutical Group Description and Business Overview
6.11.3 Shanxi C&Y Pharmaceutical Group Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanxi C&Y Pharmaceutical Group Mezlocillin Sodium Injection Product Portfolio
6.11.5 Shanxi C&Y Pharmaceutical Group Recent Developments/Updates
6.12 REYOUNG
6.12.1 REYOUNG Company Information
6.12.2 REYOUNG Description and Business Overview
6.12.3 REYOUNG Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 REYOUNG Mezlocillin Sodium Injection Product Portfolio
6.12.5 REYOUNG Recent Developments/Updates
6.13 Suzhou Erye Pharmaceutical
6.13.1 Suzhou Erye Pharmaceutical Company Information
6.13.2 Suzhou Erye Pharmaceutical Description and Business Overview
6.13.3 Suzhou Erye Pharmaceutical Mezlocillin Sodium Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Suzhou Erye Pharmaceutical Mezlocillin Sodium Injection Product Portfolio
6.13.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mezlocillin Sodium Injection Industry Chain Analysis
7.2 Mezlocillin Sodium Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mezlocillin Sodium Injection Production Mode & Process Analysis
7.4 Mezlocillin Sodium Injection Sales and Marketing
7.4.1 Mezlocillin Sodium Injection Sales Channels
7.4.2 Mezlocillin Sodium Injection Distributors
7.5 Mezlocillin Sodium Injection Customer Analysis
8 Mezlocillin Sodium Injection Market Dynamics
8.1 Mezlocillin Sodium Injection Industry Trends
8.2 Mezlocillin Sodium Injection Market Drivers
8.3 Mezlocillin Sodium Injection Market Challenges
8.4 Mezlocillin Sodium Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Biosynth
INOPHA GmbH
North China Pharmaceutical
Hailing Pharm
Hainan General Sanyang Pharmaceutical
Sichuan Pharmaceutical
Jiangsu Weiqida Pharmaceutical
Shanghai Shyndec Pharmaceutical
Shandong Lukang Pharmaceutical
Hainan Meihao Xilin Biopharmaceutical
Shanxi C&Y Pharmaceutical Group
REYOUNG
Suzhou Erye Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂